ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Adamis Pharmaceuticals Resubmits Zimhi New Drug Application to FDA for the Treatment of Opioid Overdose
May 20, 2021Adamis Pharmaceuticals Corporation，today announced that the New Drug Application (NDA) was resubmitted to the U.S. Food and Drug Administration (FDA) for Zimhi™, a naloxone injection product candidate intended for the treatment of opioid overdose. -
Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual Tablet
January 02, 2019Adamis Pharmaceuticals Corporation today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for.... -
Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its Pipeline
November 28, 2018Adamis Pharmaceuticals Corporation announced today that it has been conducting pre-IND development work for a fast-dissolving sublingual tablet containing tadalafil......
Pharma Sources Insight January 2025
